D-Mannose Didn’t Head Off Repeat Urinary Tract Infections in Women

CATEGORY: WOMEN’S HEALTH

Can a daily spoonful of a special sugar stop urinary tract infections from coming back? Researchers in the UK asked exactly that about d-mannose, the supplement stacked on pharmacy shelves for this very purpose, and the answer from the largest placebo-controlled test to date is no. Among 598 women plagued by repeat infections, 51% on d-mannose had another one within six months. On placebo, 56% did. That five-point gap sits comfortably within chance.¹

Flypaper for Bacteria, at Least on Paper

The theory behind d-mannose is appealing. Most urinary tract infections start when E. coli bacteria grab onto the bladder wall using hairlike hooks that latch onto mannose, a sugar found on the bladder’s surface. Swallow enough mannose and it ends up in your urine, where it’s supposed to work like flypaper: bacteria grab the free-floating decoy instead of you, then get flushed out. Small earlier studies had hinted this might actually work. Those hints, the trial authors noted, were exactly why a rigorous test was overdue.¹

Six Months of Powder Across Ninety-Nine Clinics

The women, all adults in UK primary care, had suffered at least two infections in the previous six months or three in the past year. Anyone who has been on that treadmill knows the cost: burning days, urgent appointments, and course after course of antibiotics. Each woman took two grams of powder daily for six months. Half got d-mannose, half got a look-alike placebo, and a remote randomization service made the split so that neither the women nor anyone treating them knew whose scoop was which. The outcome being counted was simple. Who contacted a clinician with another suspected infection?¹

Five Points Shy of Mattering

The raw counts: 150 of 294 women on d-mannose had a further infection, against 161 of 289 on placebo. The difference was 5 percentage points, with a statistical range running from 13 points in d-mannose’s favor to 3 points against it. That’s a result indistinguishable from nothing. The authors’ conclusion was flat: d-mannose shouldn’t be recommended for preventing recurrent infections in this group. We’d add only that the finding is about prevention with daily powder. The trial didn’t test d-mannose against an active infection, and it didn’t test anything else on the shelf.¹

Key Takeaways

• Roughly half the women had another urinary infection within six months whether they took d-mannose or placebo, a 5-point difference that chance alone could produce.
• The test was as fair as they come: double-blind, placebo-controlled, and spread across 99 primary care clinics.
• Earlier, smaller studies that suggested a benefit were the reason this definitive trial was run at all.
• The result covers daily prevention in women with recurrent infections. It says nothing about treating an infection already underway.

References

1. Hayward G, Mort S, Hay AD, et al. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Internal Medicine. 2024;184(6):619–628. link